Bimagrumab and Tirzepatide combination therapy investigated for weight management in adults with obesity.
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Abstract
A study will evaluate Bimagrumab and Tirzepatide, alone or combined, for efficacy and safety in adults with obesity or overweight without Type 2 Diabetes.